Association between plasma genotyping and outcomes of treatment with osimertinib (AZD9291) in advanced non-small-cell lung cancer

Oxnard G.RThress K.SAlden R.SLawrance RPaweletz C.PCantarini MCHIH-HSIN YANGBarrett J.CJänne P.A.2020-05-262020-05-2620160732-183Xhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84990050278&doi=10.1200%2fJCO.2016.66.7162&partnerID=40&md5=5b35b304faecb4251fa23d5e11ad5ef3https://scholars.lib.ntu.edu.tw/handle/123456789/494972[SDGs]SDG3Association between plasma genotyping and outcomes of treatment with osimertinib (AZD9291) in advanced non-small-cell lung cancerjournal article10.1200/JCO.2016.66.7162273544772-s2.0-84990050278